Jun 16, 2020 9:00am EDT Eminent Member of the Austrian Academy of Sciences, Professor Uwe B. Sleytr, Joins Avalon GloboCare's Scientific and Clinical Advisory Board
Jun 11, 2020 9:00am EDT Avalon GloboCare Announces Three-Way Material Transfer Agreement with Weill Cornell Medicine and Arbele Limited for Development of Next Generation Cellular Immunotherapy FLASH-CAR™ Technology
Jun 08, 2020 9:00am EDT Avalon GloboCare Announces Diagnostic Platform for Point-of-Care Rapid Detection of COVID-19 (SARS-CoV-2) and Its Clinically Relevant Mutation Strains
May 08, 2020 9:00am EDT Avalon GloboCare Advances Next Generation Cellular Immunotherapy with FLASH-CAR™ Technology for Blood Cancers
Apr 28, 2020 9:00am EDT Avalon GloboCare Partners with HydroPeptide, a Leader in Epigenetics Skin Care, to Accelerate Regenerative ACTEX™ Product Development and Commercialization
Apr 20, 2020 8:30am EDT Avalon GloboCare Achieves Major Milestones Advancing Immunotherapeutic Program towards Combatting Cytokine Storm Associated with COVID-19 Lung Damage and Mortality
Feb 24, 2020 8:30am EST Avalon GloboCare to Present at the 32nd Annual ROTH Conference on March 16, 2020
Dec 20, 2019 8:30am EST Avalon GloboCare Partners with China (Nanjing) Cell Valley to Advance Cellular Medicines
Nov 20, 2019 8:30am EST Avalon GloboCare to Present at the 12th Annual LD Micro Main Event on December 10th